Locate Bio is an innovative UK MedTech company specialising in orthobiologics. It focuses on developing next-generation solutions that address unmet musculoskeletal needs, utilising industry-leading drug delivery and tissue scaffold capabilities. Its product pipeline includes LDGraft™, an rhBMP-2 product in clinical trials for lumbar interbody fusion procedures, which has received FDA Breakthrough Device designation for specific indications.
- Investment status Current
- Invested 2018
- Category Health & Life Sciences